Jacques Camerlo
Impact in
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer survivorship and care
Papers in
- Oncology 26
- Neutropenia and Cancer Infections 7
- Cancer Treatment and Pharmacology 7
- Cancer survivorship and care 4
- Hematology 15
- Hematopoietic Stem Cell Transplantation 9
- Co-authors
- Patrice Viens (33 shared papers)D Maraninchi (39 shared papers)Dominique Genre (19 shared papers)Gwénaëlle Gravis (23 shared papers)M. Resbeut (8 shared papers)François Bertucci (12 shared papers)Réda Bouabdallah (8 shared papers)Christel Protière (7 shared papers)
In The Last Decade
Jacques Camerlo
49 papers receiving 880 citations
Peers
Comparison fields: 5 of 85
- Hematology 163
- Oncology 314
- Cancer Research 161
- Genetics 87
- Urology 45
Countries citing papers authored by Jacques Camerlo
This map shows the geographic impact of Jacques Camerlo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Camerlo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Camerlo more than expected).
Fields of papers citing papers by Jacques Camerlo
This network shows the impact of papers produced by Jacques Camerlo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Camerlo. The network helps show where Jacques Camerlo may publish in the future.
Co-authors
The 25 scholars most cited alongside Jacques Camerlo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 149 | |
| 2 | 1997 | 70 | |
| 3 | 2003 | 59 | |
| 4 | 2002 | 52 | |
| 5 | 2017 | 50 | |
| 6 | 2000 | 44 | |
| 7 | 1997 | 39 | |
| 8 | 1999 | 32 | |
| 9 | Prevention of acute GVHD by in vivo use of anti-interleukin-2 receptor monoclonal antibody (33B3.1): a feasibility trial in 15 patients. | 1991 | 29 |
| 10 | 2011 | 26 | |
| 11 | 1994 | 26 | |
| 12 | 1995 | 25 | |
| 13 | 1998 | 25 | |
| 14 | Delayed administration of granulocyte colony-stimulating factor after autologous bone marrow transplantation: effect on granulocyte recovery. | 1994 | 23 |
| 15 | 1996 | 20 | |
| 16 | 1986 | 18 | |
| 17 | 2004 | 18 | |
| 18 | 1999 | 18 | |
| 19 | Phase II study of a combination of cisplatin, all-trans-retinoic acid and interferon-alpha in squamous cell carcinoma: clinical results and pharmacokinetics. | 2001 | 17 |
| 20 | A pilot study of busulfan and melphalan as preparatory regimen prior to allogeneic bone marrow transplantation in refractory or relapsed hematological malignancies. | 1996 | 17 |
About Jacques Camerlo
Jacques Camerlo is a scholar working on Oncology, Hematology, Pathology and Forensic Medicine, Cancer Research and Genetics, having authored 52 papers that have together received 928 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (9 papers), Neutropenia and Cancer Infections (7 papers), Cancer Treatment and Pharmacology (7 papers), Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (7 papers), Breast Cancer Treatment Studies (5 papers), Cancer survivorship and care (4 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Hematology (163 citations), Oncology (314 citations), Cancer Research (161 citations), Genetics (87 citations) and Urology (45 citations). Jacques Camerlo has collaborated with scholars based in France and Armenia. Frequent co-authors include Patrice Viens, D Maraninchi, Dominique Genre, Gwénaëlle Gravis, M. Resbeut, François Bertucci, Réda Bouabdallah, Christel Protière, Norbert Vey and Luc Xerri. Their work appears in journals such as Bone Marrow Transplantation, Cancer, British Journal of Haematology, Supportive Care in Cancer and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.